Jenburkt [JENBURPH] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Jenburkt

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Jenburkt wins in 10 metrics, Suven Life Sciences wins in 8 metrics, with 0 ties. Jenburkt appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricJenburktSuven Life SciencesBetter
P/E Ratio (TTM)14.89-28.01Suven Life Sciences
Price-to-Book Ratio2.8140.49Jenburkt
Debt-to-Equity Ratio2.270.00Suven Life Sciences
PEG Ratio2.91-0.34Suven Life Sciences
EV/EBITDA11.88-23.32Suven Life Sciences
Profit Margin (TTM)20.97%84.44%Suven Life Sciences
Operating Margin (TTM)23.18%-2,791.92%Jenburkt
EBITDA Margin (TTM)23.18%N/AN/A
Return on Equity18.66%-146.15%Jenburkt
Return on Assets (TTM)16.34%-118.91%Jenburkt
Free Cash Flow (TTM)$81.92M$-1.91BJenburkt
Dividend Yield2.48%N/AN/A
1-Year Return8.77%45.66%Suven Life Sciences
Price-to-Sales Ratio (TTM)3.12641.26Jenburkt
Enterprise Value$4.67B$43.40BSuven Life Sciences
EV/Revenue Ratio3.02577.38Jenburkt
Gross Profit Margin (TTM)81.65%100.00%Suven Life Sciences
Revenue per Share (TTM)$351$0Jenburkt
Earnings per Share (Diluted)$73.46$-8.15Jenburkt
Beta (Stock Volatility)0.380.86Jenburkt
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Jenburkt vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Jenburkt
Suven Life Sciences
Jenburkt Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Jenburkt-0.42%-1.85%-5.15%-20.20%5.78%-11.50%
Suven Life Sciences0.76%-6.65%-0.56%-18.38%69.66%61.86%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Jenburkt8.77%96.74%188.92%120.06%1,195.02%2,298.67%
Suven Life Sciences45.66%184.80%304.79%-26.43%589.02%3,699.08%

News Based Sentiment: Jenburkt vs Suven Life Sciences

Jenburkt

News based Sentiment: MIXED

September presented a mixed bag for Jenburkt Pharmaceuticals, with positive year-over-year growth in revenue and profit countered by short-term declines and a negative market sentiment. The closure of the trading window signals an upcoming earnings release that will be pivotal in shaping the company's investment narrative.

View Jenburkt News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Jenburkt vs Suven Life Sciences

MetricJENBURPHSUVEN
Market Information
Market Cap i₹4.87B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,945185,019
90 Day Avg. Volume i1,278147,095
Last Close₹1,074.90₹208.63
52 Week Range₹936.70 - ₹1,410.00₹102.50 - ₹299.99
% from 52W High-23.77%-30.45%
All-Time High₹1,410.00 (Jul 08, 2025)₹338.50 (Apr 13, 2015)
% from All-Time High-23.77%-38.37%
Growth Metrics
Quarterly Revenue Growth0.09%0.86%
Quarterly Earnings Growth0.05%0.86%
Financial Health
Profit Margin (TTM) i0.21%0.84%
Operating Margin (TTM) i0.23%-27.92%
Return on Equity (TTM) i0.19%-1.46%
Debt to Equity (MRQ) i2.270.00
Cash & Liquidity
Book Value per Share (MRQ)₹389.23₹5.04
Cash per Share (MRQ)₹52.44₹2.75
Operating Cash Flow (TTM) i₹252.79M₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹320.61M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i2.48%N/A
Last 12-Month Dividend i₹33.30₹0.00

Valuation & Enterprise Metrics Analysis: Jenburkt vs Suven Life Sciences

MetricJENBURPHSUVEN
Price Ratios
P/E Ratio (TTM) i14.89-28.01
Forward P/E i31.3810.55
PEG Ratio i2.91-0.34
Price to Sales (TTM) i3.12641.26
Price to Book (MRQ) i2.8140.49
Market Capitalization
Market Capitalization i₹4.87B₹48.20B
Enterprise Value i₹4.67B₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i3.02577.38
Enterprise to EBITDA i11.88-23.32
Risk & Other Metrics
Beta i0.380.86
Book Value per Share (MRQ) i₹389.23₹5.04

Financial Statements Comparison: Jenburkt vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)JENBURPHSUVEN
Revenue/Sales i₹355.27M₹18.67M
Cost of Goods Sold i₹65.18M₹0
Gross Profit i₹290.09M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹82.35M₹-521.17M
EBITDA i₹110.14M₹-501.49M
Pre-Tax Income i₹101.82M₹-515.17M
Income Tax i₹23.90M₹0
Net Income (Profit) i₹77.92M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)JENBURPHSUVEN
Cash & Equivalents i₹73.65M₹150.26M
Total Current Assets i₹565.32M₹754.72M
Total Current Liabilities i₹188.19M₹234.86M
Long-Term Debt i₹14.92MN/A
Total Shareholders Equity i₹1.72B₹1.10B
Retained Earnings i₹1.62B₹-6.01B
Property, Plant & Equipment i₹144.29M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)JENBURPHSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricJENBURPHSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,945185,019
Average Daily Volume (90 Day) i1,278147,095
Shares Outstanding i4.41M218.07M
Float Shares i1.77M67.61M
% Held by Insiders i0.73%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Jenburkt vs Suven Life Sciences

MetricJENBURPHSUVEN
Last 12-Month Dividend i₹33.30₹0.00
Last 12-Month Dividend Yield i2.48%N/A
3-Year Avg Annual Dividend i₹19.90₹0.00
3-Year Avg Dividend Yield i1.83%N/A
3-Year Total Dividends i₹59.70₹0.00
Ex-Dividend DateJul 11, 2025N/A